Charles Schwab Investment Management Inc Arcturus Therapeutics Holdings Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 190,077 shares of ARCT stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190,077

Previous 194,629 2.34%

Holding current value

$4.16 Million

Previous $2.06 Million 19.94%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$8.91 - $14.41 $40,558 - $65,594	-4,552 Reduced 2.34%	190,077 $2.47 Million
Q1 2025 Sep 15, 2025	BUY	$10.59 - $20.83 $48,205 - $94,818	4,552 Added 2.39%	194,629 $2.06 Million
Q1 2025 May 09, 2025	SELL	$10.59 - $20.83 $139,502 - $274,393	-13,173 Reduced 6.34%	194,629 $2.06 Million
Q4 2024 Feb 06, 2025	BUY	$14.82 - $25.48 $150,867 - $259,386	10,180 Added 5.15%	207,802 $3.53 Million
Q3 2024 Nov 12, 2024	BUY	$18.08 - $25.38 $58,289 - $81,825	3,224 Added 1.66%	197,622 $4.59 Million
Q2 2024 Aug 12, 2024	BUY	$24.35 - $44.39 $88,439 - $161,224	3,632 Added 1.9%	194,398 $4.73 Million
Q1 2024 May 08, 2024	BUY	$31.23 - $42.99 $139,160 - $191,563	4,456 Added 2.39%	190,766 $6.44 Million
Q4 2023 Feb 06, 2024	BUY	$17.71 - $32.97 $41,954 - $78,105	2,369 Added 1.29%	186,310 $5.87 Million
Q3 2023 Nov 08, 2023	BUY	$25.44 - $37.35 $138,266 - $202,997	5,435 Added 3.04%	183,941 $4.7 Million
Q2 2023 Aug 09, 2023	SELL	$23.94 - $32.36 $20,827 - $28,153	-870 Reduced 0.49%	178,506 $5.12 Million
Q1 2023 May 11, 2023	BUY	$14.72 - $23.97 $12,144 - $19,775	825 Added 0.46%	179,376 $4.3 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $109,259 - $178,184	7,727 Added 4.52%	178,551 $3.03 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $190,086 - $322,345	14,566 Added 9.32%	170,824 $2.53 Million
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $20,927 - $53,207	1,707 Added 1.1%	156,258 $2.46 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $65,338 - $146,567	3,704 Added 2.46%	154,551 $4.17 Million
Q4 2021 Feb 11, 2022	BUY	$34.2 - $47.56 $44,015 - $61,209	1,287 Added 0.86%	150,847 $5.58 Million
Q3 2021 Nov 16, 2021	BUY	$27.88 - $58.25 $137,699 - $287,696	4,939 Added 3.42%	149,560 $7.15 Million
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $157,190 - $256,660	6,095 Added 4.4%	144,621 $4.89 Million
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $104,470 - $234,336	2,696 Added 1.98%	138,526 $5.72 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $650,252 - $2.32 Million	18,788 Added 16.05%	135,830 $5.89 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $3.13 Million - $5.27 Million	83,449 Added 248.41%	117,042 $5.02 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $425,287 - $1.96 Million	33,593 New	33,593 $1.57 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Arcturus Therapeutics Holdings Inc. Transaction History